IPSEN (OTCMKTS:IPSEY) Shares Cross Above 200 Day Moving Average – What’s Next?

IPSEN (OTCMKTS:IPSEY) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $38.24 and traded as high as $44.0080. IPSEN shares last traded at $44.0080, with a volume of 245 shares changing hands.

Analyst Ratings Changes

IPSEY has been the topic of several research reports. UBS Group lowered shares of IPSEN from a “strong-buy” rating to a “hold” rating in a research note on Thursday, January 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of IPSEN in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, IPSEN has a consensus rating of “Hold”.

IPSEN Price Performance

The stock’s fifty day moving average is $43.92 and its two-hundred day moving average is $38.39.

About IPSEN

Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.

The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).